
Assessing the Risk of Omalizumab Add-on Therapy for Chronic Idiopathic Urticaria during the COVID-19 Pandemic
J Clin Aesthet Dermatol. 2021;14(12):64–65. by Shikha Walia, BS; Mirjana G. Ivanic BA; Zainab A. Jafri, DO; and Jashin J. Wu, MD Dr. Walia is with Lake Erie College of Osteopathic